logo
3d render of dna structure abstract background
3d render of dna structure abstract background

Portfolio

3d render of dna structure abstract background
3d render of dna structure abstract background

Top 10 Quoted Investments

Below are the top 10 quoted investments held by the Trust with their contribution to the Trust's Net Asset Value as at 28 February 2023. For links directly to the companies' website, please click the logos.
For a full listing of the Trust's U.S. securities at each quarter end, please refer to the Trust's 13F filing: https://www.sec.gov/cgi-bin/browse-edgar?CIK=942257

Seagen logo og
 Seagen 10.0% NAV Logo_Amgen
 Amgen 5.9% NAV Harmony Biosciences
 Harmony Biosciences 5.0% NAV Cl025yvz4010cosfnn0qrskxs supernus full
 Supernus 4.5% NAV Alkermes plc Logo
 Alkermes 4.4% NAV Unknown
 Uniqure 4.3% NAV Incyte logo svg
 Incyte 4.1% NAV Intra Cellular Logo resize3
 Intra-Cellular 3.5% NAV Mirati logo
 Mirati Therapeutics 3.1% NAV Exelixislogo
 Exelixis 2.6% NAV

Venture Fund Investments

SV Fund VI

6.6% NAV as at 31 August 2022.
An investment in a venture capital fund, SV Fund VI, which invests in unquoted portfolio companies across three sectors: biotechnology, healthcare & IT and medical devices. The Trust made a commitment of $30m to the fund on 19 October 2016, equivalent to 7.5% of the total commitments, which will be drawn down over the investment period.

Directly-held Unquoted Investments

Below are the directly-held unquoted investments held by the Trust with their contribution to the Trust's Net Asset Value as at 31 August 2022.

logo_Autifony
 Autifony Therapeutics 0.1% NAV

Exited with Contingent Milestones

Exited unquoted companies for which the Trust retains rights to receive future contingent performance-based payments are shown below, including their contribution to the Trust's Net Asset Value as at 31 August 2022.

Disclaimer

The information on this website may only be suitable for certain types of investors and is not intended to be used or relied upon by any other person.

An investment with IBT may contain significant risks and is intended only for sophisticated investors who meet certain eligibility criteria.

The material on this website is intended to be viewed only by persons resident in the UK.

The information on this website is not an offer to sell or a solicitation of an offer and does not constitute investment advice.

No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained therein.

The information on this website may constitute financial promotion for the purposes of the Financial Services and Markets Act 2000 (“FSMA”).


I do not accept →